Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2023 SS
- Pathophysiologie (WA)
- Blockpraktikum Innere Medizin (PV)
- Neurochirurgisch-endokrinologische Konferenz / Endokrines Tumorzentrum am WTZ
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
- Kolloquium Endokrinologie und Stoffwechsel (*)
- Wahlfach Klinische Endokrinologie und Diabetologie
- Differentialdiagnose Innere Krankheiten
- Klinische Visite neuroendokrine Tumoren
- Innere Medizin für Studierende im Praktischen Jahr (*)
- Seminare für Doktoranden in der Endokrinologie und Diabetologie
- Klinische Visite Endokrinologie und Stoffwechsel
- Wiss. Arbeiten, Klinik für Endokrinologie, Diabetologie und Stoffwechsel
Vergangene Veranstaltungen (max. 10)
-
2022 WS
- Neurochirurgisch-endokrinologische Konferenz / Endokrines Tumorzentrum am WTZ
- Pathophysiologie (WA)
- Kolloquium Endokrinologie und Stoffwechsel (*)
- Wahlfach Klinische Endokrinologie und Diabetologie
- Blockpraktikum Innere Medizin (PV)
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
- Wiss. Arbeiten, Klinik für Endokrinologie, Diabetologie und Stoffwechsel
- Differentialdiagnose Innere Krankheiten
- Klinische Visite neuroendokrine Tumoren
- Innere Medizin für Studierende im Praktischen Jahr (*)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion : know the condition and do not mistake for adenomaIn: Pituitary Jg. 26 (2023) Nr. 1, S. 164 - 170ISSN: 1573-7403; 1386-341XOnline Volltext: dx.doi.org/ (Open Access)
-
Pre-Surgery Patient Health Contributes to Aggravated Sino-Nasal Outcome and Quality of Life after Pituitary AdenomectomyIn: Medicina Jg. 59 (2023) Nr. 1,ISSN: 1648-9144; 1010-660XOnline Volltext: dx.doi.org/ (Open Access)
-
Clonidine suppression test for a reliable diagnosis of pheochromocytoma : When to useIn: Clinical Endocrinology (2022) in pressISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with PheochromocytomaIn: Journal of Nuclear Medicine (JNM) / Society of Nuclear Medicine and Molecular Imaging (SNMMI) (Hrsg.) Jg. 63 (2022) Nr. 6, S. 869 - 874ISSN: 1535-5667; 0161-5505; 2159-662X; 0022-3123; 0097-9058Online Volltext: dx.doi.org/
-
Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in EuropeIn: European Journal of Endocrinology (EJE) Jg. 186 (2022) Nr. 5, S. K17 - K24ISSN: 1479-683X; 0804-4643; 0001-5598Online Volltext: dx.doi.org/ (Open Access)
-
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyIn: Endocrine Jg. 75 (2022) Nr. 1, S. 293 - 302ISSN: 1559-0100; 1355-008X; 0969-711XOnline Volltext: dx.doi.org/ (Open Access)
-
Adults’ Adherence to Growth Hormone Replacement in Relation to Medication-Related Beliefs, Coping and Quality of Life : An Exploratory AnalysisIn: Frontiers in Endocrinology Jg. 12 (2021)ISSN: 1664-2392Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Distinct Late-Night Salivary Cortisol Cut-Off Values for the Diagnosis of HypercortisolismIn: Hormone and Metabolic Research Jg. 53 (2021) Nr. 10, S. 662 - 671ISSN: 0018-5043; 1439-4286Online Volltext: dx.doi.org/
-
Illness-related burden, personal resources and need for support in patients with acromegaly : Results of a focus group analysisIn: Growth Hormone and IGF Research Jg. 60-61 (2021)ISSN: 1532-2238; 1096-6374Online Volltext: dx.doi.org/
-
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas -A German SurveyIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 105 (2020) Nr. 3, S. e660 - e675ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/ (Open Access)
-
Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism : The patients‘ perspectiveIn: Pituitary Jg. 23 (2020) Nr. 5, S. 479 - 487ISSN: 1573-7403; 1386-341XOnline Volltext: dx.doi.org/ (Open Access)
-
Neuroendokrine Neoplasien des VerdauungstraktsIn: Best Practice Onkologie Jg. 15 (2020) Nr. 7-8, S. 320 - 333ISSN: 1862-8559; 0946-4565Online Volltext: dx.doi.org/
-
Phäochromozytomatose nach Adrenalektomie : Metastasierung oder Zellverschleppung?In: Der Chirurg Jg. 91 (2020) Nr. 4, S. 345 - 353ISSN: 0009-4722; 1433-0385Online Volltext: dx.doi.org/
-
Prevalence of Osteopathologies in Children and Adolescents After Diagnosis of Acute Lymphoblastic LeukemiaIn: Frontiers in Pediatrics Jg. 8 (2020)ISSN: 2296-2360Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Erratum zu: Inzidentalome der Nebennieren : Diagnostisches und therapeutisches Konzept aus endokrinologischer SichtIn: Der Chirurg Jg. 90 (2019) Nr. 3, S. 235 - 235ISSN: 1433-0385; 0009-4722Online Volltext: dx.doi.org/ (Open Access)
-
Inzidentalome der Nebennieren : Diagnostisches und therapeutisches Konzept aus endokrinologischer SichtIn: Der Chirurg Jg. 90 (2019) Nr. 1, S. 3 - 8ISSN: 1433-0385; 0009-4722Online Volltext: dx.doi.org/
-
Resistance to GHRH but Not to PTH in a 15-year-old boy with pseudohypoparathyroidism 1AIn: Journal of the Endocrine Society Jg. 3 (2019) Nr. 7, S. 1383 - 1389ISSN: 2472-1972Online Volltext: dx.doi.org/ (Open Access)
-
Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 65ISSN: 1619-7070; 1619-7089
-
Children, adolescents and young adults with PWS present with low-normal bone mineral content despite treatment with growth hormone during childhoodIn: Hormone Research in Paediatrics Jg. 88 (2017) Nr. Suppl. 1, S. 260 - 260ISSN: 0018-5051; 1663-2818Online Volltext: dx.doi.org/
-
Genetische Ursachen bei endokrinen Erkrankungen am Beispiel endokriner TumorsyndromeIn: Deutsche Medizinische Wochenschrift - DMW Jg. 142 (2017) Nr. 9, S. 665 - 672ISSN: 1439-4413; 0012-0472; 1437-5982Online Volltext: dx.doi.org/
-
Loss of Functional Osteoprotegerin : More Than a Skeletal ProblemIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 102 (2017) Nr. 1, S. 210 - 219ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/
-
Loss of Functional Osteoprotegerin : More than a Skeletal ProblemIn: Hormone Research in Paediatrics Jg. 86 (2016) Nr. Suppl. 1, S. 523 - 523ISSN: 0018-5051; 1663-2818Online Volltext: dx.doi.org/
-
Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of EverolimusIn: Targeted Oncology Jg. 11 (2016) Nr. 5, S. 667 - 675ISSN: 1776-260X; 1776-2596Online Volltext: dx.doi.org/
-
Sunitinib Efficacy in Patients with Advanced pNET in Clinical PracticeIn: Hormone and Metabolic Research Jg. 48 (2016) Nr. 9, S. 575 - 580ISSN: 1439-4286; 0018-5043Online Volltext: dx.doi.org/
-
Health-Related Quality-of-Life (HRQoL) in Patients (pts) with Advanced Neuroendocrine Tumors (NET) Treated with Everolimus (EVE) : Results from an Open-Label, Phase IIIb, Multicenter, Expanded Access Program (EAP)
11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 5-7, 2014,In: Neuroendocrinology Jg. 99 (2014) Nr. 3-4, S. 277ISSN: 0028-3835; 1423-0194 -
Safety and Quality-Of-Life (QOL) Assessments in the Open-Label, Multicenter, Phase 3b, Expanded Access Study of Everolimus in Patients with Advanced Neuroendocrine Tumors (NET)In: Pancreas Jg. 43 (2014) Nr. 3, S. 500 - 501ISSN: 1536-4828; 0885-3177Online Volltext: dx.doi.org/
-
Streptozotocin-based chemotherapy in pNET : A single-centre experienceIn: Experimental and Clinical Endocrinology & Diabetes Jg. 122 (2014) Nr. 3, S. P108ISSN: 0947-7349Online Volltext: dx.doi.org/
-
Malignant Prolactinoma - a therapeutic challengeIn: Experimental and Clinical Endocrinology & Diabetes Jg. 121 (2013)ISSN: 0947-7349Online Volltext: dx.doi.org/
-
Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET)In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15, Suppl., S. 4138ISSN: 0732-183X; 1527-7755
-
Quality-of-life (QoL) assessments in patients (pts) with pancreatic neuroendocrine tumors (pNET) enrolled in the open-label, phase 3b, multicenter, expanded access study of everolimus in pts with advanced NETIn: European Journal of Cancer Jg. 49 (2013) Nr. Suppl. 2, S. 619ISSN: 0959-8049
-
User Profiles of a Smartphone Application to Support Drug Adherence - Experiences from the iNephro ProjectIn: PLoS ONE Jg. 8 (2013) Nr. 10, S. e78547ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissuesIn: Experimental and Clinical Endocrinology & Diabetes Jg. 120 (2012) Nr. 8, S. 482 - 489ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
Effects of standard glucocorticoid replacement therapies on subjective well-being : A randomized, double-blind, crossover study in patients with secondary adrenal insufficiencyIn: European Journal of Endocrinology Jg. 167 (2012) Nr. 5, S. 679 - 685ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/
-
Pasireotide (SOM230), a Novel Multireceptor‐Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7‐Day Subcutaneous Infusion in Healthy Male VolunteersIn: Journal of Clinical Pharmacology Jg. 52 (2012) Nr. 7, S. 1017 - 1027ISSN: 0021-9754; 1552-4604; 0091-2700Online Volltext: dx.doi.org/
-
Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal massIn: Experimental and Clinical Endocrinology & Diabetes Jg. 120 (2012) Nr. 8, S. 494 - 500ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers : A Single-Center, Open-Label, Ascending-Dose StudyIn: Clinical Therapeutics Jg. 34 (2012) Nr. 3, S. 677 - 688ISSN: 0149-2918; 1879-114XOnline Volltext: dx.doi.org/
-
Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center ExperienceIn: Hormone and Metabolic Research Jg. 43 (2011) Nr. 12, S. 838 - 843ISSN: 1439-4286Online Volltext: dx.doi.org/
-
Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia : Utility of salivary 17α- hydroxyprogesterone day profilesIn: Experimental and Clinical Endocrinology & Diabetes Jg. 119 (2011) Nr. 3, S. 131 - 138ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine : a Single-Center ExperienceIn: Experimental and Clinical Endocrinology & Diabetes Jg. 119 (2011) Nr. 9, S. 540 - 543ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
⁶⁸Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUV mₐₓIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 38 (2011) Nr. 7, S. 1224 - 1236ISSN: 1619-7089; 1619-7089; 1432-105X; 0340-6997Online Volltext: dx.doi.org/
-
Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasmaIn: Clinical Endocrinology Jg. 73 (2010) Nr. 2, S. 153 - 160ISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/
-
Randomized, Double-Blinded, Cross-Over Study Comparing Various Glucocorticoid Substitution Schemes in Secondary Adrenal Insufficiency
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine reviews: issued quarterly for the Endocrine Society Jg. 31 (2010) Nr. Suppl. 1,ISSN: 0163-769X; 1945-7189Online Volltext: dx.doi.org/ -
Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research Jg. 40 (2008) Nr. 3, S. 181 - 188ISSN: 0018-5043; 1439-4286Online Volltext: dx.doi.org/
-
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumoursIn: Clinical Endocrinology Jg. 68 (2008) Nr. 6, S. 850 - 857ISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/
-
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal massIn: European Journal of Endocrinology Jg. 154 (2006) Nr. 3, S. 409 - 417ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/ (Open Access)
-
Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4, and 5 in various adrenal tumorsIn: Endocrine Research Jg. 30 (2004) Nr. 4, S. 931 - 934ISSN: 0743-5800; 1532-4206Online Volltext: dx.doi.org/
-
Efficacy and safety of 124-I-MIBG guided high activity 131-I-MIBG therapy of metastatic pheochromocytoma and neuroblastomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290 - S291ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105X
-
Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 65ISSN: 1619-7089Online Volltext: dx.doi.org/
-
Pre-treatment intensity of DOTATOC uptake for prediction of response to selective intravascular radionuclide therapy
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 42 (2015) Nr. Suppl. 1, S. S8 - S9ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Chemotherapy in the Treatment of Progressive, Undifferentiated Neuroendocrine Carcinomas : A Single-Center Experience
7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease March 11–12, 2010 Berlin, Germany,In: Neuroendocrinology Jg. 92 (2010) Nr. 1, S. 27ISSN: 0028-3835; 1423-0194Online Volltext: dx.doi.org/